Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

2.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

290
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
290
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

61
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
61

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Road Not Yet Taken: Cell-Free DNA PCR Testing For Coccidioidomycosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.

The Journal of antimicrobial chemotherapy·2026
Same author

Immunomodulation in Disseminated Coccidioidomycosis: A Small Step or a Giant Leap?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Development Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases.

Open forum infectious diseases·2026
Same author

Coccidioidomycosis-Attributable Death in the United States: An Analysis of Cases Reported on Death Certificates, 2018-2023.

Journal of fungi (Basel, Switzerland)·2025
Same author

Coccidioidomycosis in Europe: a systematic literature review of epidemiology, treatment and outcomes.

The Journal of antimicrobial chemotherapy·2025
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Related Experiment Video

Updated: May 22, 2025

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

6.9K

Coccidioidomycosis: a growing global concern.

Fariba M Donovan1,2,3, Omar Marín Fernández4, Gurjinder Bains5

  • 1Valley Fever Center for Excellence, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.

The Journal of Antimicrobial Chemotherapy
|March 14, 2025
PubMed
Summary
This summary is machine-generated.

Coccidioidomycosis (CM) is a fungal infection from inhaled spores. While often asymptomatic, it can cause severe pulmonary or disseminated disease, highlighting the need for better diagnostics and treatments.

More Related Videos

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
10:33

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure

Published on: May 27, 2022

5.3K
Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
09:06

Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research

Published on: March 29, 2024

652

Related Experiment Videos

Last Updated: May 22, 2025

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

6.9K
Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
10:33

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure

Published on: May 27, 2022

5.3K
Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
09:06

Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research

Published on: March 29, 2024

652

Area of Science:

  • Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Coccidioidomycosis (CM) is a fungal infection caused by Coccidioides spp.
  • Endemic to desert soils in the southwestern USA, Mexico, and parts of Central and South America.
  • Exposure occurs through inhalation of airborne arthroconidia, often due to natural events or outdoor activities.

Purpose of the Study:

  • To provide an overview of Coccidioidomycosis (CM).
  • To highlight the clinical spectrum and geographical distribution of the disease.
  • To emphasize the urgent need for improved diagnostics and treatments.

Main Methods:

  • Literature review on Coccidioides spp. and Coccidioidomycosis.
  • Analysis of disease prevalence and clinical manifestations.
  • Assessment of current diagnostic and treatment challenges.

Main Results:

  • Approximately 60% of infections are asymptomatic.
  • 30% of cases present with pulmonary symptoms, ranging from flu-like illness to pneumonia.
  • 5%-10% of infections develop into serious or disseminated disease, with 1%-3% affecting the CNS and potentially being fatal.

Conclusions:

  • Coccidioidomycosis presents a significant public health concern in endemic regions.
  • A substantial proportion of infections lead to severe or life-threatening conditions.
  • There is a critical unmet need for advancements in CM diagnostics and therapeutics.